These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14173466)

  • 41. Experimental infection of horses with A-equi 2-Miami-1-63 and human A2-Hong Kong-1-68 influenza viruses. 3. Immunodiffusion study of the antibody response.
    Styk B; Blaskovic D; Sabó A; Hána L; Kapitáncik B; Kaplan M
    Acta Virol; 1970 Jan; 14(1):35-46. PubMed ID: 4392075
    [No Abstract]   [Full Text] [Related]  

  • 42. Improved dextran sulfate-calcium chloride method for the removal of nonspecific inhibitors with modifications for nonspecific agglutinin removal in the rubella hemagglutination inhibition test.
    Nelson DB; Quirin EP; Inhorn SL
    Appl Microbiol; 1972 Aug; 24(2):264-9. PubMed ID: 4672319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ON THE ALLEGED ANTIGENIC RELATION BETWEEN ECHO VIRUS TYPES 29 AND 32.
    ROSEN L; BEHBEHANI AM; KAMITSUKA PS; KERN J; LENNETTE EH; MELNICK JL; SCHMIDT NJ; WENNER HA
    Proc Soc Exp Biol Med; 1965 Jul; 119():908-10. PubMed ID: 14330904
    [No Abstract]   [Full Text] [Related]  

  • 44. [SEROLOGIC RESPONSE OF THE HORSE TO INJECTION OF HUMAN AND EQUINE TYPE A STRAINS OF INFLUENZA VIRUS].
    MAROIS P; PAVILANIS V; GILKER JC
    Rev Can Biol; 1964 Sep; 23():285-9. PubMed ID: 14237161
    [No Abstract]   [Full Text] [Related]  

  • 45. THE INOCULATION OF CALVES WITH PARAINFLUENZA 3 VIRUS.
    DAWSON PS; DARBYSHIRE JH; LAMONT PH
    Res Vet Sci; 1965 Jan; 6():108-13. PubMed ID: 14281659
    [No Abstract]   [Full Text] [Related]  

  • 46. MOUSE BETA-1C-GLOBULIN: PRODUCTION OF ANTISERUM AND CHARACTERIZATION IN THE COMPLEMENT REACTION.
    MARDINEY MR; MUELLER-EBERHARD HJ
    J Immunol; 1965 Jun; 94():877-82. PubMed ID: 14321431
    [No Abstract]   [Full Text] [Related]  

  • 47. CHROMATOGRAPHY OF GUINEA PIG COMPLEMENT AND SERUM COFACTOR ON SEPHADEX G-200.
    STYK B; HANA L; KOCISKOVA D; RATHOVA V
    Acta Virol; 1964 May; 8():283. PubMed ID: 14173477
    [No Abstract]   [Full Text] [Related]  

  • 48. HETEROTYPIC HAEMAGGLUTINATION INHIBITION IN THE ADENOVIRUS GROUP.
    NASZ I; LENGYEL A; DAN P; KULCSAR G
    Acta Microbiol Acad Sci Hung; 1963-1964; 10():379-85. PubMed ID: 14160954
    [No Abstract]   [Full Text] [Related]  

  • 49. [CHROMATOGRAPHY OF INFLUENZA VIRUSES A AND A2 WITH ANTI-INFLUENZA SERUM AND A BIOLOGICALLY NEUTRAL COMPLEX OF VIRUS-ANTIBODY WITH SEPHADEX G-200].
    ZHUMATOV KhZh; SAIATOV MKh
    Vopr Virusol; 1964; 42():555-9. PubMed ID: 14256617
    [No Abstract]   [Full Text] [Related]  

  • 50. DEMONSTRATION OF HUMAN MEASLES ANTIBODY BY MIXED AGGLUTINATION.
    BARRON AL; MILGROM F; KARZON DT; WITEBSKY E
    J Immunol; 1963 Jun; 90():908-13. PubMed ID: 14050201
    [No Abstract]   [Full Text] [Related]  

  • 51. COFACTOR AND SPECIFIC ANTIBODIES AGAINST INFLUENZA VIRUSES. 8. ON THE DIFFERENT NATURE OF "ANTIBODY COFACTOR" AND COMPLEMENT.
    STYK B; KOCISKOVA D; HANA L
    Acta Virol; 1964 Nov; 8():496-506. PubMed ID: 14242988
    [No Abstract]   [Full Text] [Related]  

  • 52. Neutralization and hemagglutination inhibition of swine influenza virus by serum from suckling swine and by milk from their dams.
    YOUNG GA; UNDERDAHL NR
    J Immunol; 1950 Oct; 65(4):369-73. PubMed ID: 14794899
    [No Abstract]   [Full Text] [Related]  

  • 53. SEROEPIDEMIOLOGICAL STUDIES OF MYXOVIRUS PARAINFLUENZAE 3 INFECTION.
    FUKUMI H; NORIKI H
    Jpn J Med Sci Biol; 1963 Jun; 16():93-105. PubMed ID: 14048403
    [No Abstract]   [Full Text] [Related]  

  • 54. A TWENTY-ONE-YEAR EXPERIENCE WITH ANTIGENIC VARIATION AMONG INFLUENZA B VIRUSES.
    HENNESSY AV; MINUSE E; DAVENPORT FM
    J Immunol; 1965 Feb; 94():301-6. PubMed ID: 14265902
    [No Abstract]   [Full Text] [Related]  

  • 55. Immunochemical studies on myxoviruses. I. Heterogeneity of V-antigens obtained y disruption influenza viruses.
    Neurath AR; Rubin BA; Pierzchala WA
    Z Naturforsch B; 1967 Aug; 22(8):850-5. PubMed ID: 4384763
    [No Abstract]   [Full Text] [Related]  

  • 56. COFACTOR AND SPECIFIC ANTIBODIES AGAINST INFLUENZA VIRUSES. X. FORMATION OF 19S AND 7S TYPE INFLUENZA ANTIBODIES IN YOUNG AND ADULT RABBITS AND IN ROOSTERS; THE ROLE OF ANTIBODY COFACTOR.
    STYK B; HANA L
    Acta Virol; 1965 May; 9():200-9. PubMed ID: 14328218
    [No Abstract]   [Full Text] [Related]  

  • 57. DIFFERENCES IN THE MECHANISM OF IN VITRO IMMUNE HEMOLYSIS RELATED TO ANTIBODY SPECIFICITY.
    SEARS DA; WEED RI; SWISHER SN
    J Clin Invest; 1964 May; 43(5):975-85. PubMed ID: 14169526
    [No Abstract]   [Full Text] [Related]  

  • 58. [INHIBITION OF VIRUS HEMAGGLUTINATION BY VIRUS-INFECTED AND NON-INFECTED MOUSE LUNGS. DESCRIPTION OF A TISSUE INHIBITOR].
    BIENZ K; LAZARY S; LOEFFLER H
    Pathol Microbiol (Basel); 1965; 28():151-7. PubMed ID: 14299859
    [No Abstract]   [Full Text] [Related]  

  • 59. SELECTIVE HEMAGGLUTINATION OF MYXOVIRUSES.
    LOBODZINSKA M; KIDANKIEWICZ T; SKURSKA Z
    Arch Immunol Ther Exp (Warsz); 1964; 12():164-72. PubMed ID: 14166656
    [No Abstract]   [Full Text] [Related]  

  • 60. EXPERIMENTAL ENTERITIS PRODUCED IN DOGS BY ESCHERICHIA COLI ENDOTOXIN.
    MULLENS JE; MCKAY KA; JUBB KV
    Can J Surg; 1964 Jan; 7():79-88. PubMed ID: 14106542
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.